Effect of trimethoprim-sulphamethoxazole on the risk of malaria in HIV-infected Ugandan children living in an area of widespread antifolate resistance

BACKGROUND: Daily trimethoprim-sulfamethoxazole (TS) protects against malaria, but efficacy may be diminished as anti-folate resistance increases. This study assessed the incidence of falciparum malaria and the prevalence of resistance-conferring Plasmodium falciparum mutations in HIV-infected child...

Descripción completa

Detalles Bibliográficos
Autores principales: Gasasira, Anne F, Kamya, Moses R, Ochong, Edwin O, Vora, Neil, Achan, Jane, Charlebois, Edwin, Ruel, Theodore, Kateera, Fredrick, Meya, Denise N, Havlir, Diane, Rosenthal, Philip J, Dorsey, Grant
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2903607/
https://www.ncbi.nlm.nih.gov/pubmed/20573194
http://dx.doi.org/10.1186/1475-2875-9-177

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2903607/
https://www.ncbi.nlm.nih.gov/pubmed/20573194
http://dx.doi.org/10.1186/1475-2875-9-177

Ejemplares similares